foxo4 dri peptide senolytic 2024 study Frontiers foxo4-dri peptide senolytic mouse study
foxo4 dri peptide senolytic mouse study 2023 2024 Molecular modelling of the FOXO4 TP53 interaction to design peptides for the elimination of senescent cancer cells FOXO4 DRI Peptide for Cellular The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4 DRI Nature Communications Buy FOXO4 DRI 10mg Third Party Tested BioEdge Peptides Peptide inhibitors targeting FOXO4 p53 interactions and inducing senescent cancer cell specific apoptosis bioRxiv
Pay in 4 interest-free payments of $7.38 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11



